Clinical Trials · NCT07812636
Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer
- Phase
- EARLY_Phase 1
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Milton S. Hershey Medical Center
- Enrollment
- 15
- Start date
- Nov 2026
- Locations
- 1 site, United States
- Primary endpoint
- Pathologic Response at 6 months from Cycle 1 Day 1